PREFERENCES FOR ADJUVANT CHEMOTHERAPY IN AN ANZGOG SUBSTUDY OF THE PORTEC-3 INTERGROUP RANDOMIZED CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER.

被引：0
|
作者：
Blinman, P. [1 ]
Mileshkin, L. [2 ]
Khaw, P. [2 ]
Goss, G. [3 ]
Johnson, C. [4 ]
Capp, A. [5 ]
Brooks, S. [6 ]
Wain, G. [7 ]
Kolodzeij, I. [8 ]
Veillard, A. S. [8 ]
Creutzberg, C. [9 ]
Stockler, M. [8 ]
机构：
[1] Concord Canc Ctr, Concord, CA USA
[2] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[3] Monash Med Ctr, Melbourne, Vic, Australia
[4] Wellington Hosp, Wellington, New Zealand
[5] Calvary Mater Newcastle, Auckland, New Zealand
[6] Auckland City Hosp, Auckland, New Zealand
[7] Westmead Hosp, Sydney, NSW, Australia
[8] NHMRC Clin Trials Ctr, Sydney, NSW, Australia
[9] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0739
引用
收藏
页码：1482 / 1483
页数：2
相关论文
共 50 条
  • [31] CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH MELPHALAN FOR BREAST-CANCER
    RUBENS, RD
    KNIGHT, RK
    FENTIMAN, IS
    HOWELL, A
    CROWTHER, D
    GEORGE, WD
    HAYWARD, JL
    BULBROOK, RD
    CHAUDARY, M
    BUSH, H
    SELLWOOD, RA
    HOWAT, JMT
    LANCET, 1983, 1 (8329): : 839 - 843
  • [32] Chemotherapy as Adjuvant Treatment for Early Stage Endometrial Cancer With High Intermediate Risk Factors
    Gao, Min
    Zhang, Naiyi
    Song, Nan
    Zheng, Hong
    Yan, Xin
    Gao, Yunong
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (07) : 1285 - 1289
  • [33] Outcomes after adjuvant sequential chemotherapy and radiotherapy for high-risk endometrial cancer
    Fullerton, R.
    Zahra, M.
    Stille, A.
    Morgan, J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1159 - S1160
  • [34] Adjuvant Concurrent Chemoradiation and Chemotherapy for High Risk Non-Metastatic Endometrial Cancer
    Rajan, R.
    Kunheri, D. B.
    Tatineni, D. T.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S597 - S597
  • [35] 'SANDWICH' ADJUVANT CHEMOTHERAPY AND RADIOTHERAPY IN HIGH RISK ENDOMETRIAL CANCER: TWO INSTITUTION EXPERIENCE
    Ferrero, A.
    Danese, R.
    Fuso, L.
    Danese, S.
    Gribaudo, S.
    Rossi, A.
    Attianese, D.
    Villa, M.
    Biglia, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A320 - A320
  • [36] Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Jurgenliemk-Schulz, Ina M.
    Kitchener, Henry C.
    Nijman, Hans W.
    Wilson, Godfrey
    Brooks, Susan
    Carinelli, Silvestro
    Provencher, Diane
    Hanzen, Chantal
    Lutgens, Ludy C. H. W.
    Smit, Vincent T. H. B. M.
    Singh, Naveena
    Do, Viet
    D'Amico, Romerai
    Nout, Remi A.
    Feeney, Amanda
    Verhoeven-Adema, Karen W.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2018, 19 (03): : 295 - 309
  • [37] Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial
    de Boer, Stephanie M.
    Powell, Melanie E.
    Mileshkin, Linda
    Katsaros, Dionyssios
    Bessette, Paul
    Haie-Meder, Christine
    Ottevanger, Petronella B.
    Ledermann, Jonathan A.
    Khaw, Pearly
    Colombo, Alessandro
    Fyles, Anthony
    Baron, Marie-Helene
    Kitchener, Henry C.
    Nijman, Hans W.
    Kruitwagen, Roy F.
    Nout, Remi A.
    Verhoeven-Adema, Karen W.
    Smit, Vincent T.
    Putter, Hein
    Creutzberg, Carien L.
    LANCET ONCOLOGY, 2016, 17 (08): : 1114 - 1126
  • [38] RELATION BETWEEN PATIENT AND PHYSICIAN REPORTED TOXICITY IN THE RANDOMISED PORTEC-3 TRIAL OF RADIATION THERAPY (RT) WITH OR WITHOUT CHEMOTHERAPY FOR ENDOMETRIAL CANCER
    De Boer, S. M.
    Powell, M. E.
    Mileshkin, L.
    Katsaros, D.
    Bessette, P.
    Haie-Meder, C.
    Nout, R. A.
    Kitchener, H. C.
    Ottevanger, P. B.
    Khaw, P.
    Colombo, A.
    Fyles, A.
    Baron, M. H.
    Nijman, H. W.
    Kruitwagen, R.
    Ledermann, J.
    Verhoeven-Adema, K. W.
    Smit, V. T.
    Putter, H.
    Creutzberg, C. L.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 278 - 279
  • [39] A randomized controlled trial of an educational intervention for managing fatigue in women receiving adjuvant chemotherapy for early stage breast cancer.
    Yates, P
    Grove, K
    Aranda, S
    MacCallum, P
    Hargraves, M
    McLaughlan, S
    Mirolo, B
    Milne, D
    MacCallum, P
    ONCOLOGY NURSING FORUM, 2004, 31 (02) : 382 - 382
  • [40] CHEMOTHERAPY INDUCED AMENORRHEA IN A RANDOMIZED TRIAL OF ADJUVANT CHEMOTHERAPY DURATION IN BREAST-CANCER
    REYNO, LM
    LEVINE, MN
    SKINGLEY, P
    ARNOLD, A
    ABUZAHRA, H
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 21 - 23
12345